搜索结果

Search Results for " μ opioid receptor agonist 3 "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T79430	μ opioid receptor agonist 3	Opioid Receptor	Endocrinology/Hormones; GPCR/G Protein; Neuroscience
	μopioid receptor agonist3 (compound 20) 是高效的μOR激动剂，其EC50 值为0.87 nM。该化合物在疼痛和神经精神适应症研究中具备潜在应用价值。
TP1882L1	Orphanin FQ(1-11) acetate(178249-41-7 free base)	Opioid Receptor	Endocrinology/Hormones; GPCR/G Protein; Neuroscience
	Orphanin FQ(1-11) acetate(178249-41-7 free base) 含有 Nociceptin 氨基酸 1-11 的肽片段。 ORL1/KOR-3 受体的强效激动剂 (Ki = 55 nM)；对阿片受体无亲和力，包括 μ、δ、κ1 和 κ3 受体 (Ki >1000 nM)。在 CD-1 小鼠中显示镇痛特性。
T62025	μ opioid receptor agonist 2
	μ opioid receptor agonist 2 （Compound H-3）是一种MOR 受体激动剂，可用于疼痛及疼痛相关疾病的研究。
T72423	Endomorphin 1 acetate
	Endomorphin 1 acetate，一种高度选择性的，高亲和力的μ-opioid 受体激动剂 (Ki: 1.11 nM)，对 kappa3结合位点具有高亲和力，Ki 值为 20 到 30 nM 之间。Endomorphin 1 acetate 具有镇痛特性。
T83709	LIH383 TFA Phe-Gly-Gly-Phe-Met-Arg-Arg-Lys-NH2
	LIH383是一种趋化因子(C-X-C motif) 受体7 (CXCR7)的多肽激动剂，属于趋化因子和阿片肽清除受体。它专一性激活CXCR7 (EC50 = 0.61 nM)，在3 µM浓度时，相比μ-、δ-、κ-阿片受体以及诺氨酸阿片肽（NOP）受体的β-arrestin招募实验中表现出高选择性。LIH383（3 µM）通过阻止U87-ACKR3细胞中，由非选择性阿片受体激动剂dynorphin A诱导的CXCR7对阿片肽的摄取，发挥作用。
TP1882	Orphanin FQ(1-11) Orphanin FQ (1-11)
	Orphanin FQ(1-11) is a peptide fragment containing amino acids 1-11 of Nociceptin. Orphanin FQ(1-11) is a potent agonist of the ORL1/KOR-3 receptor (Ki = 55 nM) and displays no affinity for opioid receptors, including μ, δ, κ1 and κ3 receptors (Ki >1000 nM). Orphanin FQ(1-11) displays analgesic properties in CD-1 mice.
T36722	Deltorphin II (trifluoroacetate salt)
	Deltorphin II is a peptide agonist of δ2-opioid receptors.1,2It is selective for δ-opioid receptors over μ- and κ-opioid receptors in radioligand bindings assays (Kis = 0.0033, >1, and >1 μM, respectively) and induces [35S]GTPγS binding in mouse brain membrane preparations (EC50= 0.034 μM). Deltorphin II (0.12 mg/kg) decreases the infarction zone:risk zone ratio in a rat model of myocardial ischemia-reperfusion injury induced by coronary occlusion, an effect that can be reversed by the δ2-opioid...